Peptide record

TPDB45755

Antiviral standard
35 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45755
Antiviral
Anti-infective peptides
DRAVP 2.0 Peptipedia
standard
No
A 35-aa standard-residue antiviral peptide sequence curated from DRAVP 2.0 and Peptipedia, with an available 3D structural model.
Sequence
LGNVNNSISNALDKLEESNSKLDKVNVKLTGTSAL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C156H269N45O57
RCQHMFPWY
NL
3687.12
7.09
4
4
12
+0
1.81
-0.380
108.57
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
0
0.00
13
Residue Composition
number
2
A
0
R
6
N
2
D
0
C
2
E
0
Q
2
G
0
H
1
I
6
L
4
K
0
M
0
F
0
P
5
S
2
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 2 R: 0 N: 6 D: 2 C: 0 E: 2 Q: 0 G: 2 H: 0 I: 1 L: 6 K: 4 M: 0 F: 0 P: 0 S: 5 T: 2 W: 0 Y: 0 V: 3
Chemical Descriptors
35 reviewed residue count
C156H269N45O57 sequence-only estimate (linear, free termini)
3687.12 sequence-only estimate (linear, free termini)
7.09 sequence-only estimate (linear, free termini)
+0 sequence-only estimate (linear, free termini)
1.81 sequence-only estimate (linear, free termini)
-0.380 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0